GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
When government lives off the sick
Have you bought a drug lately? From “simple” analgesic to the complex ones for serious ailments such as cancer, asthma, diabetes or hypertension, the prices are now so outrageously out
U.S. Ambassador commends Nigerian Technovation Champions
ABUJA – U.S. Ambassador W. Stuart Symington praised the ingenuity and determination of the Nigerian winners of the 2015 Technovation Challenge. The four girls and their mentor, Team Charis,
WHO to distribute Paediatric chewable worm medicine to endemic countries
The World Health Organization (WHO) will begin distributing a paediatric (chewable) formulation of mebendazole to countries with a high prevalence of soil-transmitted helminthiases (intestinal worms). Mebendazole is one of the
0 Comments
No Comments Yet!
You can be first to comment this post!